All In Biotech

Free tool

FAERS Monitor: Hyrimoz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761071 or its brand name (Hyrimoz, Adalimumab-Adaz). Reports on generic versions are filed under their own applications.

Reports

55,076

Serious

50,853

92% of reports

Hospitalization

19,018

Death reported

8,503

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective11,624
  • off label use9,662
  • rheumatoid arthritis6,561
  • pain6,472
  • fatigue6,470
  • arthralgia6,308
  • rash5,346
  • condition aggravated5,087
  • diarrhoea4,907
  • drug intolerance4,718
  • nausea4,651
  • joint swelling4,643
  • headache4,639
  • systemic lupus erythematosus4,632
  • psoriatic arthropathy4,430

Reports by year received

View as table
YearReports
20048
200525
200610
200744
2008136
2009138
2010257
2011208
2012256
2013295
2014277
2015318
2016505
2017727
20181,255
20192,236
20203,159
20213,641
20225,374
20238,070
202410,487
202510,501
20267,149

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,999,083 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
systemic lupus erythematosusSignal4,63257.255.5222,587
psoriatic arthropathySignal4,43046.745.3176,652
rheumatoid arthritisSignal6,56123.422.8133,017
drug intoleranceSignal4,71819.619.079,367
joint swellingSignal4,64315.214.859,715
condition aggravatedSignal5,0876.56.323,521
arthralgiaSignal6,3085.95.725,586
rashSignal5,3464.74.615,853
off label useSignal9,6624.24.224,774
painSignal6,4724.14.015,184
drug ineffectiveSignal11,6243.43.320,701
fatigueSignal6,4703.23.110,026
diarrhoeaSignal4,9072.92.86,330
headacheSignal4,6392.82.85,653
nauseaSignal4,6512.32.23,341

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.